Protecting the Brain During Cardiac Arrest: New Research from MCIRCC'S Pre-Clinical Lab
“Sudden cardiac arrest (CA) is a leading cause of death in the U.S., affecting approximately 430,000 individuals annually with an overall mortality rate of close to 90%. Furthermore, approximately two-third of the patients resuscitated from out-of-hospital CA ultimately die from neurologic injury, and up to half of the survivors have cognitive dysfunction. No pharmacologic agent has yet been established as neuroprotective for CA victims.”
Published in Resuscitation Plus, new research from the MCIRCC Pre-Clinical Lab studies valproic acid as a potential means of enhancing neuroprotection in a model of cardiac arrest.